Improving Global Access to Life Changing Therapeutics

Navigate Global Regulatory, Operational & Supply Complexities to Accelerate Patient Access, Harness Ethical Real-World Data, & Deliver Scalable Expanded Access Programs

EAPs are evolving rapidly, moving from reactive programs to strategic, patient-centered initiatives that shape global access. Organizations are navigating unprecedented complexity: collecting meaningful real-world data without overburdening sites, managing multi-country supply chains, integrating AI and digital tools to forecast demand and streamline operations, and meeting stringent regulatory and ethical requirements. At the same time, emerging markets and LMICs are becoming critical frontiers, requiring scalable, compliant solutions to ensure timely patient access. This evolving landscape demands actionable strategies, cross-functional collaboration, and innovative approaches to deliver care efficiently, ethically, and at scale.

The 6th Operationalize: Expanded Access Programs Summit brings together 140+ experts leading global EAP strategy and operations to share the tools, partnerships, and processes transforming access delivery today.

As a first-time attendee, I really enjoyed the conference, which is a unique opportunity to network, learn from other companies, who have been very openly sharing their best practices and lessons learnt - that's truly remarkable

Astra Zeneca

I enjoyed the speakers, the content, and the ability to network with others. There were reputable vendors and pharma companies, of all sizes, which I appreciated.

Takeda

Was great to meet global colleagues and peers under one roof. What stood out was openness, willingness to share, networking opportunities and lots of learning.

Sowaka Logo

Explore the Full Event Guide

  • Navigate global regulatory changes and deliver compliant programs worldwide
  • Optimize data collection to balance access, ethics, and evidence
  • Harness digital tools and AI to enhance oversight and efficiency
  • Build resilient supply strategies to meet unpredictable patient demand
  • Streamline collaboration across access, clinical, and supply functions
brochure

Gain Fresh Insights Into:

Expand Access in LMICs

With scalable, compliant models that overcome regulatory and infrastructure barriers

Leverage Real-World Data

To generate credible evidence that informs trials, approvals, and long-term outcomes

Build Ethical, Sustainable Chargeable Access Models

That balance transparency, equity, and impact

Streamline Logistics with AI-driven Forecasting

To maintain supply continuity and operational efficiency

Accelerate Access for Rare and Gene Therapies

Through data-led case studies that connect innovation to patients

Biotech-Focused Program Design

Manage regulatory, supply and commercial responsibilities efficiently

What To Expect

140+

Access Leaders from Pharma, Biotech, and Beyond

25+

Expert Speakers Shaping the Future of Early Access

8+

Hours of Structured Networking

3

Days of Actionable Insights and Peer Learning

2

Dedicated Workshop Tracks for All Levels of Experience

1

Global Forum for the Expanded Access Community

Attending Companies Include

Sanofi
Daiichi Sankyo
Astra Zeneca
Takeda
Regeneron
the Max Foundation
Ferring Pharmaceuticals
Scholar Rock
Savara Pharmaceuticals
Event image
Explore the Agenda

Uncover practical insights from leading access, operations, and medical affairs experts through real-world case studies, interactive discussions, and hands-on workshops designed to help you build, manage, and scale compliant, patient-focused Expanded Access Programs worldwide

Event image
Partner With Us

Showcase how your solutions empower sponsors to operationalize access - from supply chain and digital workflow tools to regulatory consultancy and real-world data systems

Event image
Join the Global EAP Community

Be part of the only meeting uniting 140+ access leaders across pharma, biotech, and service providers. Exchange practical experience, shape global best practices, and collaborate on solutions that advance equitable, ethical, and scalable access for patients in need

.